• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Addex to lead mGlu7 NAM-focused PTSD consortium pharmaceutical-technology
    July 10, 2019
    Swiss-headquartered Addex Therapeutics has announced it will lead a consortium to develop small molecule negative allosteric modulators (NAMs) indicated to reduce fear memory in post-traumatic stress disorder (PTSD).
  • Addex joins UK drug and brain research initiative pharmatimes
    September 27, 2018
    Swiss group Addex Therapeutics has joined a UK-based initiative established to study the role of the D1 receptor...

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service